Clinical Trial Update: A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update for Lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis. The study is currently active and not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Dermatitis, Atopic, Eczema | Phase 3 | Status: ACTIVE_NOT_RECRUITING